IT8748160A0 - USE OF BROMOCRIPTINE IN AUTO-IMMUNE DISEASES - Google Patents

USE OF BROMOCRIPTINE IN AUTO-IMMUNE DISEASES

Info

Publication number
IT8748160A0
IT8748160A0 IT8748160A IT4816087A IT8748160A0 IT 8748160 A0 IT8748160 A0 IT 8748160A0 IT 8748160 A IT8748160 A IT 8748160A IT 4816087 A IT4816087 A IT 4816087A IT 8748160 A0 IT8748160 A0 IT 8748160A0
Authority
IT
Italy
Prior art keywords
bromocriptine
auto
immune diseases
immune
diseases
Prior art date
Application number
IT8748160A
Other languages
Italian (it)
Other versions
IT1224222B (en
Inventor
Douglas Larson
Peter Hiestand
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8748160A0 publication Critical patent/IT8748160A0/en
Application granted granted Critical
Publication of IT1224222B publication Critical patent/IT1224222B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT48160/87A 1986-07-14 1987-07-10 USE OF BROMOCRIPTINA IN AUTO-IMMUNE AFFECTIONS IT1224222B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14

Publications (2)

Publication Number Publication Date
IT8748160A0 true IT8748160A0 (en) 1987-07-10
IT1224222B IT1224222B (en) 1990-09-26

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48160/87A IT1224222B (en) 1986-07-14 1987-07-10 USE OF BROMOCRIPTINA IN AUTO-IMMUNE AFFECTIONS

Country Status (13)

Country Link
JP (1) JPS6323817A (en)
KR (1) KR880001292A (en)
AU (1) AU602154B2 (en)
CH (1) CH672987A5 (en)
DE (1) DE3722383A1 (en)
DK (1) DK363887A (en)
FR (1) FR2601245A1 (en)
GB (1) GB2192541B (en)
IT (1) IT1224222B (en)
NL (1) NL8701631A (en)
PH (1) PH24525A (en)
SE (1) SE8702843L (en)
ZA (1) ZA875145B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (en) * 1987-05-07 1988-11-17 Sandoz Ag NEW APPLICATION OF DOPAMINE RECEPTOR AGONISTS
EP0327040A3 (en) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Use of dopamine and/or dopamine agonists to prepare a medicine for the treatment of the digestive tract
US5716933A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
WO1993012793A1 (en) * 1991-12-23 1993-07-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College A therapeutic process for the treatment of the pathologies of type ii diabetes
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
PT2091537E (en) 2006-11-23 2013-08-29 Sinoxa Pharma Gmbh Pharmaceutical compositions for the treatment of capillary arteriopathy
DK3445362T3 (en) * 2016-04-20 2021-10-11 Veroscience Llc Composition and method of treatment of metabolic diseases
EP4233913A3 (en) 2017-10-18 2023-10-18 VeroScience LLC Improved bromocriptine formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (en) * 1968-05-31 1971-05-15 Sandoz Ag Process for the preparation of 2-bromo-a-ergocryptine
CH666406A5 (en) * 1984-02-29 1988-07-29 Sandoz Ag METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
CH672987A5 (en) 1990-01-31
ZA875145B (en) 1989-02-22
SE8702843L (en) 1988-01-15
KR880001292A (en) 1988-04-22
SE8702843D0 (en) 1987-07-13
NL8701631A (en) 1988-02-01
DK363887D0 (en) 1987-07-13
IT1224222B (en) 1990-09-26
FR2601245A1 (en) 1988-01-15
DE3722383A1 (en) 1988-01-28
GB8716323D0 (en) 1987-08-19
GB2192541B (en) 1990-05-02
JPS6323817A (en) 1988-02-01
AU7558787A (en) 1988-01-21
GB2192541A (en) 1988-01-20
DK363887A (en) 1988-01-15
PH24525A (en) 1990-07-18
AU602154B2 (en) 1990-10-04

Similar Documents

Publication Publication Date Title
IT8748160A0 (en) USE OF BROMOCRIPTINE IN AUTO-IMMUNE DISEASES
DE3790726T1 (en) Cosmetic sample
IT1211852B (en) COMPOSITION OF ISOTONIC HUMETTING EYEWASH
AU7121987A (en) Use of dipropyleneglycolmonomethyl ether in hair shaping compounds
IT8767787A0 (en) COMPOSITION OF TOOTHPASTE IN GEL FORMS
DK633587D0 (en) PHARMACOLOGICAL / COSMETIC PREPARATION
DK668487A (en) COSMETIC PREPARATION
KR880701524A (en) Composition of 1-oxohydrocarbyl-substituted azacyclohexane and use thereof
IT1173329B (en) PROCEDURE FOR THE QUANTITATIVE TRANSFORMATION OF TEICOPLANINA A2 FACTOR 1 TO TEICOPLANINA A2 FACTOR 3
FR2589687B1 (en) ARTIFICIAL HAIR
DK483487D0 (en) UNKNOWN PREPARATION
FR2593392B1 (en) COSMETIC COMPOSITION
DK41585D0 (en) EXPRESSION OF HUMAN ALFA-1-ANTITRYPSIN IN GAER
SE8705060D0 (en) ANTI-COOLING KIT, ANTI-COOLING PREPARATION AND USE OF IT
KR880701616A (en) abrasive
IT1231426B (en) PREPARATION OF POLYFLUOROENOLATES
IT1232167B (en) COSMETIC USE OF 3-INDOLPIRUVIC ACID
SE456221B (en) BACKGROUND OF RADIATIONS, IN PARTICULAR S SOLARIES
TR23414A (en) AUGMENTATION AND POLISHING PREPARATION AND YOENTEM
FR2605881B1 (en) HEMORROIDAL DRESSING
KR870013007U (en) Cosmetic tattoo utensils
ES1000381Y (en) BIOLECTROMAGNETIC FOOTWEAR FOR THERAPEUTIC AND GENERAL USE
KR880000044A (en) Shoes of far-infrared use
BR6601898U (en) OBJECT OF SPECIFIC USE
BR6601440U (en) SET OF CUTLERY